The fact is no one knows what is going to happen and everything is pure speculation. The company will be sold, merge or as a last result BK. The shorts fill this board will junk, not to mention they cant spell which credits skill level in trading.
The CEO needs to come out with some news this week before the stock goes under $1 but the good thing is the Longs are not letting that happen with a healthy support line. The value of the company should be around 2.50 (post debt) a share as is assuming the CEO is not hiding any news that would further hurt the stock. Hopefully the company will be bought and the drug released down the line but at a minimum anyone who bought under $2 should get their money back from a sale or merger.